A change is needed in the landscape of preclinical models to test drugs that target aging.

Ladiges W

DOI: 10.31491/apt.2024.12.162
Published: 2024 Dec
Container: Aging pathobiology and therapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.31491/apt.2024.12.162,
  title = {A change is needed in the landscape of preclinical models to test drugs that target aging.},
  author = {Ladiges W},
  year = {2024},
  journal = {Aging pathobiology and therapeutics},
  doi = {10.31491/apt.2024.12.162},
  url = {https://doi.org/10.31491/apt.2024.12.162}
}

RIS

TY  - JOUR
TI  - A change is needed in the landscape of preclinical models to test drugs that target aging.
AU  - Ladiges W
PY  - 2024
JO  - Aging pathobiology and therapeutics
DO  - 10.31491/apt.2024.12.162
UR  - https://doi.org/10.31491/apt.2024.12.162
ER  -

APA

W, L. (2024). A change is needed in the landscape of preclinical models to test drugs that target aging.. Aging pathobiology and therapeutics. https://doi.org/10.31491/apt.2024.12.162

Source records

pubmed · retrieved 2026-09-26T20:46:18.146Z